225 related articles for article (PubMed ID: 29463107)
1. Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic.
Bhat S; Kansal M; Kondos GT; Groo V
Ann Pharmacother; 2018 Aug; 52(8):724-732. PubMed ID: 29463107
[TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a pharmacist-managed heart failure medication titration clinic.
Martinez AS; Saef J; Paszczuk A; Bhatt-Chugani H
Am J Health Syst Pharm; 2013 Jun; 70(12):1070-6. PubMed ID: 23719886
[TBL] [Abstract][Full Text] [Related]
4. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study.
Santema BT; Ouwerkerk W; Tromp J; Sama IE; Ravera A; Regitz-Zagrosek V; Hillege H; Samani NJ; Zannad F; Dickstein K; Lang CC; Cleland JG; Ter Maaten JM; Metra M; Anker SD; van der Harst P; Ng LL; van der Meer P; van Veldhuisen DJ; Meyer S; Lam CSP; ; Voors AA
Lancet; 2019 Oct; 394(10205):1254-1263. PubMed ID: 31447116
[TBL] [Abstract][Full Text] [Related]
5. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs.
Hyman DA; Siebert VR; Birnbaum GD; Alam M; Birnbaum Y
Cardiovasc Drugs Ther; 2020 Apr; 34(2):215-221. PubMed ID: 32219664
[TBL] [Abstract][Full Text] [Related]
6. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.
Chin KL; Skiba M; Tonkin A; Reid CM; Liew D; Krum H; Hopper I
Heart Fail Rev; 2016 Nov; 21(6):675-697. PubMed ID: 27465132
[TBL] [Abstract][Full Text] [Related]
7. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
[TBL] [Abstract][Full Text] [Related]
8. Characteristics Associated with Upper-Range Doses of Beta-Blockers and Angiotensin-Renin Inhibitors in Reduced Ejection Fraction.
Itzhaki Ben Zadok O; Murninkas D; Iakobishvili Z; Jino H; Yohananov E; Birkenfeld S; Hasdai D
Isr Med Assoc J; 2020 Jul; 22(7):441-445. PubMed ID: 33236570
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
10. Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF).
Patil T; Ali S; Kaur A; Akridge M; Eppes D; Paarlberg J; Parashar A; Jarmukli N
J Cardiovasc Transl Res; 2022 Dec; 15(6):1424-1435. PubMed ID: 35501544
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the Potential of Primary Care Pharmacists to Improve Heart Failure Management.
Slade J; Lee M; Park J; Liu A; Heidenreich P; Allaudeen N
Jt Comm J Qual Patient Saf; 2022 Jan; 48(1):25-32. PubMed ID: 34848159
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Verma S; Dhingra NK; Butler J; Anker SD; Ferreira JP; Filippatos G; Januzzi JL; Lam CSP; Sattar N; Peil B; Nordaby M; Brueckmann M; Pocock SJ; Zannad F; Packer M;
Lancet Diabetes Endocrinol; 2022 Jan; 10(1):35-45. PubMed ID: 34861154
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy.
Martens P; Verbrugge FH; Nijst P; Bertrand PB; Dupont M; Tang WH; Mullens W
J Card Fail; 2017 Aug; 23(8):597-605. PubMed ID: 28284756
[TBL] [Abstract][Full Text] [Related]
14. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
[TBL] [Abstract][Full Text] [Related]
15. Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand.
Teng TK; Tay WT; Ouwerkerk W; Tromp J; Richards AM; Gamble G; Greene SJ; Yiu KH; Poppe K; Ling LH; Lund M; Sim D; Devlin G; Loh SY; Troughton R; Ren QW; Jaufeerally F; Lee SGS; Tan RS; Soon DKN; Leong G; Ong HY; Yeo DPS; Lam CSP; Doughty RN
ESC Heart Fail; 2023 Apr; 10(2):1280-1293. PubMed ID: 36722315
[TBL] [Abstract][Full Text] [Related]
16. Improving medication titration in heart failure by embedding a structured medication titration plan.
Hickey A; Suna J; Marquart L; Denaro C; Javorsky G; Munns A; Mudge A; Atherton JJ
Int J Cardiol; 2016 Dec; 224():99-106. PubMed ID: 27643473
[TBL] [Abstract][Full Text] [Related]
17. Heart failure medication dosage and survival in women and men seen at outpatient clinics.
Bots SH; Onland-Moret NC; Tulevski II; van der Harst P; Cramer MJM; Asselbergs FW; Somsen GA; den Ruijter HM
Heart; 2021 Nov; 107(21):1748-1755. PubMed ID: 34261736
[TBL] [Abstract][Full Text] [Related]
18. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice.
Smith KV; Dunning JR; Fischer CM; MacLean TE; Bosque-Hamilton JW; Fera LE; Grant JY; Zelle DJ; Matta L; Gaziano TA; MacRae CA; Scirica BM; Desai AS
J Pharm Pract; 2022 Oct; 35(5):747-751. PubMed ID: 33813934
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy doses at hospital discharge in patients with existing and de novo heart failure.
Diamant MJ; Virani SA; MacKenzie WJ; Ignaszewski A; Toma M; Hawkins NM
ESC Heart Fail; 2019 Aug; 6(4):774-783. PubMed ID: 31218850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
